These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33157228)

  • 21. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
    Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial.
    Overduin LA; Koopman JPR; Prins C; Verbeek-Menken PH; De Pijper CA; Eblé PL; Heerink F; van Genderen PJJ; Grobusch MP; Visser LG
    Lancet Infect Dis; 2024 Feb; 24(2):206-216. PubMed ID: 37802090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabies vaccination in Japan.
    Wilde H; Hemachudha T
    Vaccine; 2009 Jan; 27(2):181. PubMed ID: 19007834
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.
    Kositprapa C; Limsuwun K; Wilde H; Jaijaroensup W; Saikasem A; Khawplod P; Kri-aksorn U; Supich C
    Clin Infect Dis; 1997 Sep; 25(3):614-6. PubMed ID: 9314448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation.
    Kewcharoenwong C; Freeouf S; Nithichanon A; Petsophonsakul W; Pornprasert S; Khamduang W; Suzuki T; Onodera T; Takahashi Y; Lertmemongkolchai G
    Med Microbiol Immunol; 2024 May; 213(1):7. PubMed ID: 38761268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabies pre-exposure prophylaxis using intradermal human diploid cell vaccine: immunologic efficacy and cost-effectiveness in a university medical center and a review of selected literature.
    Morrison AJ; Hunt EH; Atuk NO; Schwartzman JD; Wenzel RP
    Am J Med Sci; 1987 May; 293(5):293-7. PubMed ID: 3109240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antigenic properties of concentrated antirabies vaccine in accelerated immunization schedules].
    Mad'iarova RS; Dulina AV; Krutilina DV; Latypova RG; Morogova VM
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):95-8. PubMed ID: 7445860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization.
    Dreesen DW; Fishbein DB; Kemp DT; Brown J
    Vaccine; 1989 Oct; 7(5):397-400. PubMed ID: 2815976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination.
    Jaijaroensup W; Limusanno S; Khawplod P; Serikul K; Chomchay P; Kaewchomphoo W; Tantawichien T; Wilde H
    J Travel Med; 1999 Dec; 6(4):234-7. PubMed ID: 10575171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.
    Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization.
    Permpalung N; Wongrakpanich S; Korpaisarn S; Tanratana P; Angsanakul J
    Vaccine; 2013 Aug; 31(38):4079-83. PubMed ID: 23845809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis.
    Mills DJ; Lau CL; Mills C; Furuya-Kanamori L
    J Travel Med; 2022 Mar; 29(2):. PubMed ID: 34875078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis.
    Warrell MJ
    Curr Top Microbiol Immunol; 2012; 351():139-57. PubMed ID: 21267707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
    Roukens AH; Vossen AC; van Dissel JT; Visser LG
    Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
    Soentjens P; Andries P; Aerssens A; Tsoumanis A; Ravinetto R; Heuninckx W; van Loen H; Brochier B; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Feb; 68(4):607-614. PubMed ID: 29939243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.